The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease
171-181
Brugtts, J.J.
dd677c36-9a1a-4b67-aa6f-4efc829a4200
De Maat, M.P.
af233c02-1516-411d-bb09-45e170570957
Boersma, E.
5a8488c6-e03f-4496-9437-981f6d4e5243
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
2009
Brugtts, J.J.
dd677c36-9a1a-4b67-aa6f-4efc829a4200
De Maat, M.P.
af233c02-1516-411d-bb09-45e170570957
Boersma, E.
5a8488c6-e03f-4496-9437-981f6d4e5243
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
Brugtts, J.J., De Maat, M.P., Boersma, E. and Curzen, N.
(2009)
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
Cardiovascular Drugs and Therapy, 23 (2), .
(doi:10.1007/s10557-008-6156-1).
(PMID:19082699)
This record has no associated files available for download.
More information
Published date: 2009
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 355206
URI: http://eprints.soton.ac.uk/id/eprint/355206
ISSN: 0920-3206
PURE UUID: 03f59370-04ad-41ac-b26f-636bb5498490
Catalogue record
Date deposited: 06 Aug 2013 15:09
Last modified: 15 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
J.J. Brugtts
Author:
M.P. De Maat
Author:
E. Boersma
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics